These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 19344299)

  • 21. Polyunsaturated fatty acid supplementation for ADHD symptoms: response to commentary.
    Sinn N
    J Dev Behav Pediatr; 2007 Jun; 28(3):262-3. PubMed ID: 17565297
    [No Abstract]   [Full Text] [Related]  

  • 22. Physical fatty acid deficiency signs in children with ADHD symptoms.
    Sinn N
    Prostaglandins Leukot Essent Fatty Acids; 2007 Aug; 77(2):109-15. PubMed ID: 17825546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Role of Nutritional Supplements in the Treatment of ADHD: What the Evidence Says.
    Lange KW; Hauser J; Lange KM; Makulska-Gertruda E; Nakamura Y; Reissmann A; Sakaue Y; Takano T; Takeuchi Y
    Curr Psychiatry Rep; 2017 Feb; 19(2):8. PubMed ID: 28168597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of polyunsaturated fatty acids in reducing child attention deficit and hyperactivity disorders.
    Transler C; Eilander A; Mitchell S; van de Meer N
    J Atten Disord; 2010 Nov; 14(3):232-46. PubMed ID: 20424008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review of cognitive, cognitive-behavioral, and neural-based interventions for Attention-Deficit/Hyperactivity Disorder (ADHD).
    Toplak ME; Connors L; Shuster J; Knezevic B; Parks S
    Clin Psychol Rev; 2008 Jun; 28(5):801-23. PubMed ID: 18061324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Broad-spectrum micronutrient treatment for attention-deficit/hyperactivity disorder: rationale and evidence to date.
    Rucklidge JJ; Kaplan BJ
    CNS Drugs; 2014 Sep; 28(9):775-85. PubMed ID: 25056569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical inquiries. Do dietary interventions improve ADHD symptoms in children?
    Ballard W; Hall MN; Kaufmann L
    J Fam Pract; 2010 Apr; 59(4):234-5. PubMed ID: 20398584
    [No Abstract]   [Full Text] [Related]  

  • 28. Complementary and Alternative Medicine (CAM): considerations for the treatment of major depressive disorder.
    Freeman MP
    J Clin Psychiatry; 2009; 70 Suppl 5():4-6. PubMed ID: 19909686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complementary and alternative medicine in urology.
    Dreikorn K
    BJU Int; 2005 Dec; 96(8):1177-84. PubMed ID: 16285876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Old and new controversies in the alternative treatment of attention-deficit hyperactivity disorder.
    Rojas NL; Chan E
    Ment Retard Dev Disabil Res Rev; 2005; 11(2):116-30. PubMed ID: 15977318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Research review: the role of diet in the treatment of attention-deficit/hyperactivity disorder--an appraisal of the evidence on efficacy and recommendations on the design of future studies.
    Stevenson J; Buitelaar J; Cortese S; Ferrin M; Konofal E; Lecendreux M; Simonoff E; Wong IC; Sonuga-Barke E
    J Child Psychol Psychiatry; 2014 May; 55(5):416-27. PubMed ID: 24552603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The diet factor in attention-deficit/hyperactivity disorder.
    Millichap JG; Yee MM
    Pediatrics; 2012 Feb; 129(2):330-7. PubMed ID: 22232312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attention-deficit/hyperactivity disorder: dietary and nutritional treatments.
    Arnold LE; Hurt E; Lofthouse N
    Child Adolesc Psychiatr Clin N Am; 2013 Jul; 22(3):381-402, v. PubMed ID: 23806311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complementary and alternative medicines and dietary interventions in multiple sclerosis: what is being used in South Australia and why?
    Leong EM; Semple SJ; Angley M; Siebert W; Petkov J; McKinnon RA
    Complement Ther Med; 2009 Aug; 17(4):216-23. PubMed ID: 19632549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complementary and alternative therapies for children and adolescents with ADHD.
    Bader A; Adesman A
    Curr Opin Pediatr; 2012 Dec; 24(6):760-9. PubMed ID: 23111680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral neuropathy: pathogenic mechanisms and alternative therapies.
    Head KA
    Altern Med Rev; 2006 Dec; 11(4):294-329. PubMed ID: 17176168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Alternative and complementary therapies in multiple sclerosis].
    Schwarz S; Leweling H; Meinck HM
    Fortschr Neurol Psychiatr; 2005 Aug; 73(8):451-62. PubMed ID: 16052439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. OROS methylphenidate for the treatment of adults with attention-deficit/hyperactivity disorder.
    Ramos-Quiroga JA; Corominas M; Castells X; Bosch R; Casas M
    Expert Rev Neurother; 2009 Aug; 9(8):1121-31. PubMed ID: 19673602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complementary medicines (herbal and nutritional products) in the treatment of Attention Deficit Hyperactivity Disorder (ADHD): a systematic review of the evidence.
    Sarris J; Kean J; Schweitzer I; Lake J
    Complement Ther Med; 2011 Aug; 19(4):216-27. PubMed ID: 21827936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural medicine and nutritional therapy as an alternative treatment in systemic lupus erythematosus.
    Patavino T; Brady DM
    Altern Med Rev; 2001 Oct; 6(5):460-71. PubMed ID: 11703166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.